Literature DB >> 9853756

Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP.

J de Rooij1, F J Zwartkruis, M H Verheijen, R H Cool, S M Nijman, A Wittinghofer, J L Bos.   

Abstract

Rap1 is a small, Ras-like GTPase that was first identified as a protein that could suppress the oncogenic transformation of cells by Ras. Rap1 is activated by several extracellular stimuli and may be involved in cellular processes such as cell proliferation, cell differentiation, T-cell anergy and platelet activation. At least three different second messengers, namely diacylglycerol, calcium and cyclic AMP, are able to activate Rap1 by promoting its release of the guanine nucleotide GDP and its binding to GTP. Here we report that activation of Rap1 by forskolin and cAMP occurs independently of protein kinase A (also known as cAMP-activated protein kinase). We have cloned the gene encoding a guanine-nucleotide-exchange factor (GEF) which we have named Epac (exchange protein directly activated by cAMP). This protein contains a cAMP-binding site and a domain that is homologous to domains of known GEFs for Ras and Rap1. Epac binds cAMP in vitro and exhibits in vivo and in vitro GEF activity towards Rap1. cAMP strongly induces the GEF activity of Epac towards Rap1 both in vivo and in vitro. We conclude that Epac is a GEF for Rap1 that is regulated directly by cAMP and that Epac is a new target protein for cAMP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853756     DOI: 10.1038/24884

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  659 in total

1.  The Ras mutant D119N is both dominant negative and activated.

Authors:  R H Cool; G Schmidt; C U Lenzen; H Prinz; D Vogt; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Involvement of a small GTP-binding protein (G protein) regulator, small G protein GDP dissociation stimulator, in antiapoptotic cell survival signaling.

Authors:  A Takakura; J Miyoshi; H Ishizaki; M Tanaka; A Togawa; Y Nishizawa; H Yoshida; S i Nishikawa; Y Takai
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

Review 3.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

4.  Combinatorial effect of T-cell receptor ligation and CD45 isoform expression on the signaling contribution of the small GTPases Ras and Rap1.

Authors:  J Czyzyk; D Leitenberg; T Taylor; K Bottomly
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 5.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

6.  Identification of four candidate cGMP targets in Dictyostelium.

Authors:  Jonathan M Goldberg; Leonard Bosgraaf; Peter J M Van Haastert; Janet L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

7.  The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus.

Authors:  E D Roberson; J D English; J P Adams; J C Selcher; C Kondratick; J D Sweatt
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

8.  Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring.

Authors:  Neal M Alto; Scott H Soderling; Naoto Hoshi; Lorene K Langeberg; Rosa Fayos; Patricia A Jennings; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

9.  Identification and characterization of two unusual cGMP-stimulated phoshodiesterases in dictyostelium.

Authors:  Leonard Bosgraaf; Henk Russcher; Helena Snippe; Sonya Bader; Joyce Wind; Peter J M Van Haastert
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

10.  Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.

Authors:  Cristina Hernández; Patricia Bogdanov; Cristina Solà-Adell; Joel Sampedro; Marta Valeri; Xavier Genís; Olga Simó-Servat; Marta García-Ramírez; Rafael Simó
Journal:  Diabetologia       Date:  2017-08-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.